Burke & Herbert EVP awarded 1,550 RSUs

TISSUE ROBERT S reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

TISSUE ROBERT S reported acquisition or exercise transactions in this Form 4 filing.

Burke & Herbert Financial Services Corp. executive vice president of financial strategy Robert S. Tissue reported receiving an equity award tied to company stock. He was granted 1,550 time-based restricted stock units that vest in three equal annual installments, each settling into one share of common stock.

After this grant, he directly holds 52,290 common shares. The filing also notes 373 common shares held indirectly through his spouse, reflecting household exposure to the stock rather than an open-market purchase or sale.

Insider Trade Summary

Grant/Award: 1,550 shares

Grant/Award 2 txns

Insider TISSUE ROBERT S

Role EVP, Financial Strategy

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	1,550	$0.00	$0.00
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 52,290 shares (Direct); Common Stock — 373 shares (Indirect, By Spouse)

Footnotes (1)

1. F1. The reporting person received an award of 1,550 time-based restricted stock units (RSUs). The award will vest in three equal annual installments subject to the reporting person's continued employment through each applicable vesting date. Each RSU will be settled in a share of Burke & Herbert Financial Services Corp. common stock.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did BHRB executive Robert S. Tissue report?

Robert S. Tissue reported receiving an equity award in the form of restricted stock units. He was granted 1,550 time-based RSUs that will vest in three equal annual installments, each converting into one share of Burke & Herbert Financial Services Corp. common stock upon vesting.

Is the BHRB Form 4 transaction a stock purchase or an award?

The Form 4 shows an award, not an open-market stock purchase. Robert S. Tissue received 1,550 time-based restricted stock units at no stated purchase price, which will vest over three years and settle in shares of Burke & Herbert Financial Services Corp. common stock.

How do the 1,550 RSUs granted to the BHRB EVP vest?

The 1,550 restricted stock units vest in three equal annual installments. Each installment is contingent on Robert S. Tissue’s continued employment through the applicable vesting date, and every vested RSU will be settled in one share of Burke & Herbert Financial Services Corp. common stock.

What is Robert S. Tissue’s share ownership in BHRB after the reported award?

Following the award, Robert S. Tissue directly holds 52,290 shares of Burke & Herbert Financial Services Corp. common stock. The Form 4 also lists 373 additional shares held indirectly through his spouse, representing separate but related beneficial ownership within his household.

Does the BHRB Form 4 include any insider sales of common stock?

The Form 4 does not report any insider sales of common stock. It records a grant of 1,550 time-based restricted stock units to Robert S. Tissue and discloses indirect ownership of 373 shares held by his spouse, without listing any sale transactions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/19/2026 - 02:24 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

TISSUE ROBERT S

(Last) (First) (Middle)

100 SOUTH FAIRFAX STREET

(Street)

ALEXANDRIA VA 22314

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Burke & Herbert Financial Services Corp. [ BHRB ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Financial Strategy

3. Date of Earliest Transaction (Month/Day/Year)
01/22/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	01/22/2026		A		1,550(1)	A	$0	52,290	D
Common Stock								373	I	By Spouse

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The reporting person received an award of 1,550 time-based restricted stock units (RSUs). The award will vest in three equal annual installments subject to the reporting person's continued employment through each applicable vesting date. Each RSU will be settled in a share of Burke & Herbert Financial Services Corp. common stock.

Remarks:

	/s/ Matthew Rucker, as Attorney-in-Fact for Robert S. Tissue	02/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.